VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VIR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VIRVir Biotechnology, Inc.
$10.25$1.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVIRQuarterly Financials

Vir Biotechnology, Inc. (VIR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Vir Biotechnology, Inc. (VIR) quarterly income statement — complete revenue, gross profit & net income history

VIR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue-29K64.07M240K1.21M3.03M12.37M2.38M3.08M56.38M16.79M2.64M3.8M62.96M49.41M374.56M-40.63M1.23B812.75M103.62M177.07M
Revenue Growth %-100.96%417.78%-89.92%-60.52%-94.62%-26.29%-9.81%-19.02%-10.45%-66.03%-99.3%109.35%-94.89%-93.92%261.49%-122.95%203612.23%269915.61%55014.89%167.2%
Cost of Goods Sold0-366.56M151.45M97.52M117.61M88.79M195.23M105.17M98.53M106.37M145.07M168.1M159.55M161.17M136.42M143M180.38M185.22M106.5M87.27M
COGS % of Revenue--572.13%63105%8032.95%3879.12%717.54%8202.86%3420%174.78%633.63%5497.01%4427.31%253.43%326.19%36.42%-351.97%14.64%22.79%102.79%49.29%
Gross Profit0430.63M-151.21M-96.31M-114.58M-76.42M-192.85M-102.09M-42.16M-89.58M-142.43M-164.31M-96.59M-111.76M238.14M-183.63M1.05B627.53M-2.89M89.8M
Gross Margin %-672.13%-63005%-7932.95%-3779.12%-617.54%-8102.86%-3320%-74.78%-533.63%-5397.01%-4327.31%-153.43%-226.19%63.58%451.97%85.36%77.21%-2.79%50.71%
Gross Profit Growth %100%663.54%21.59%5.67%-171.79%14.7%-35.4%37.87%56.35%19.84%-159.81%10.52%-109.18%-117.81%8342.92%-304.49%173798.02%208381.4%-1636.7%35.51%
Operating Expenses132.26M467.24M22.23M22.11M24.96M40.73M38.46M56.54M37.92M49.44M44.3M50.88M46.78M38.74M43.17M41.59M38.26M55.78M50.5M28.78M
OpEx % of Revenue-456072.41%729.27%9262.92%1821.33%823.35%329.2%1615.8%1838.7%67.27%294.48%1678.86%1339.95%74.3%78.41%11.53%-102.37%3.1%6.86%48.73%16.25%
Selling, General & Admin23.34M23.62M22.23M00000000000000000
SG&A % of Revenue-80479.31%36.86%9262.92%-----------------
Research & Development108.92M88.35M151.46M97.51M118.64M106.08M195.18M105.11M100.13M108.97M145.03M168.08M157.64M155.17M114.17M115.08M90.23M128.34M98.67M86.13M
R&D % of Revenue-375593.1%137.89%63109.58%8032.04%3913.09%857.31%8200.76%3418.31%177.6%649.11%5495.57%4426.73%250.4%314.05%30.48%-283.25%7.32%15.79%95.23%48.64%
Other Operating Expenses01000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-132.29M-36.61M-173.44M-118.42M-139.55M-117.15M-231.3M-158.63M-80.08M-139.02M-186.73M-215.19M-143.37M-150.5M194.96M-225.22M1.01B571.75M-53.38M61.02M
Operating Margin %456172.41%-57.15%-72267.92%-9754.28%-4602.47%-946.74%-9718.66%-5158.7%-142.05%-828.12%-7075.86%-5667.26%-227.73%-304.6%52.05%554.34%82.26%70.35%-51.52%34.46%
Operating Income Growth %5.2%68.75%25.02%25.35%-74.26%15.73%-23.87%26.28%44.14%7.63%-195.78%4.46%-114.14%-126.32%465.2%-469.11%739.1%627.43%39.07%310.03%
EBITDA-132.29M-33.72M-170.44M-115.5M-136.68M-114.26M-228.41M-154.37M-75.56M-134.54M-182.15M-210.44M-137.73M-148.55M196.65M-223.63M1.02B573.27M-51.9M62.55M
EBITDA Margin %456172.41%-52.62%-71018.75%-9514%-4507.92%-923.42%-9596.97%-5020.16%-134.04%-801.44%-6902.08%-5542.22%-218.77%-300.65%52.5%550.41%82.39%70.54%-50.09%35.33%
EBITDA Growth %3.21%70.49%25.38%25.18%-80.88%15.07%-25.4%26.64%45.14%9.43%-192.63%5.9%-113.56%-125.91%478.9%-457.5%745.79%635.44%39.78%325.95%
D&A (Non-Cash Add-back)02.9M3M2.92M2.87M2.89M2.9M4.26M4.52M4.48M4.59M4.75M5.64M1.95M1.68M1.6M1.55M1.52M1.49M1.53M
EBIT0-43.06M-162.97M-118.59M-138.53M-103.12M-218.59M-132.35M-78.48M-130.8M-183.36M-209.82M-143.37M-150.5M194.96M-225.22M1.01B611.15M-53.38M61.02M
Net Interest Income07.8M9.36M10.79M12.29M14.15M17.53M18.85M21.28M20.74M21.93M23.02M21.31M16.17M9.33M2.2M388K167K11K97K
Interest Income7.19M7.8M9.36M10.79M12.29M14.15M17.53M18.85M21.28M20.74M21.93M23.02M21.31M16.17M9.33M2.2M388K167K11K97K
Interest Expense00000000000000000000
Other Income/Expense6.76M-6.45M10.47M7.63M18.6M12.47M17.76M18.74M15.08M18.26M20.11M17.56M183K-1.14M22.77M-8.5M-91.92M-25.86M164.15M849K
Pretax Income-125.53M-43.06M-162.97M-110.79M-120.95M-104.67M-213.54M-139.89M-65M-120.76M-166.63M-197.62M-143.19M-151.64M217.73M-233.72M921.91M545.89M110.76M61.87M
Pretax Margin %432844.83%-67.21%-67905.42%-9125.86%-3989.08%-845.93%-8972.27%-4549.27%-115.3%-719.35%-6313.98%-5204.71%-227.44%-306.9%58.13%575.26%74.8%67.17%106.9%34.94%
Income Tax-170K-137K168K170K16K-86K177K-1.51M276K-4.78M-3.21M-2.85M-2.23M-50.03M42.42M-157.23M403.29M20.64M334K53K
Effective Tax Rate %0.14%0.32%-0.1%-0.15%-0.01%0.08%-0.08%1.08%-0.42%3.96%1.93%1.44%1.56%33%19.48%67.27%43.74%3.78%0.3%0.09%
Net Income-125.69M-42.92M-163.14M-110.96M-120.97M-104.59M-213.72M-138.38M-65.28M-115.97M-163.41M-194.78M-140.9M-101.6M175.31M-76.49M518.62M525.25M110.43M61.81M
Net Margin %433431.03%-66.99%-67975.42%-9139.87%-3989.61%-845.23%-8979.71%-4500.1%-115.79%-690.85%-6192.23%-5129.71%-223.8%-205.63%46.81%188.27%42.08%64.63%106.57%34.91%
Net Income Growth %-3.91%58.96%23.66%19.82%-85.31%9.82%-30.78%28.95%53.67%-14.14%-193.21%-154.63%-127.17%-119.34%58.76%-223.75%407.04%597.17%230.52%298.33%
Net Income (Continuing)-125.69M-42.92M-163.14M-110.96M-120.97M-104.59M-213.72M-138.38M-65.28M-115.97M-163.41M-194.78M-140.96M-101.6M175.31M-76.49M518.62M525.25M110.43M61.81M
Discontinued Operations00000000000000000000
Minority Interest00000000000044K0000000
EPS (Diluted)-0.85-0.31-1.17-0.80-0.88-0.76-1.56-1.02-0.48-0.86-1.22-1.45-1.06-0.761.30-0.583.853.920.820.46
EPS Growth %3.41%59.21%25%21.57%-83.33%11.63%-27.87%29.66%54.72%-13.16%-193.85%-150%-127.53%-119.39%58.54%-226.09%391.67%572.29%222.39%270.37%
EPS (Basic)-0.85-0.31-1.17-0.80-0.88-0.76-1.56-1.02-0.48-0.86-1.22-1.45-1.06-0.761.32-0.583.934.010.850.48
Diluted Shares Outstanding147.36M139.23M138.93M138.45M137.47M136.81M136.65M136.23M135.28M134.61M134.29M134.06M133.55M133.15M134.96M132.45M134.54M133.88M133.85M133.79M
Basic Shares Outstanding147.36M139.23M138.93M138.45M137.47M136.81M136.65M136.23M135.28M134.61M134.29M134.06M133.55M133.15M132.73M132.45M132.08M130.97M130.67M130.12M
Dividend Payout Ratio--------------------